WDR5 and pulmonary arterial hypertension: Downregulation of ASH2 and WD repeat domain 5 (WDR5), two key components of the H3K4 methyltransferase complex, significantly reduces CAM expression and ameliorates hypoxia‐induced PAH in mice, highlighting the therapeutic potential of targeting this pathway [226].